Home

The core function of the Screening Group (SCR) at IARC is to provide data on the accuracy, reproducibility, efficacy, benefits, harmful effects, and cost-effectiveness of various early detection interventions for breast, cervical, colorectal, and oral cancers, among others, in reducing deaths and improving patients’ quality of life in various settings. These data can then be used to inform and improve the rational use of health-care resources. The Group’s ultimate objective is to guide the development of public health policies for implementing screening in a variety of health-care settings, in particular in low- and middle-income countries (LMICs).

SCR conducts field studies in LMICs to evaluate various early detection methods for breast, cervical, colorectal, and oral cancer control. These initiatives also address the means by which screening services could be scaled up through local public health services. SCR develops various training resources to catalyse and augment capacity building in close collaboration with national institutions and government health services. Through its research programme, SCR generates scientific evidence to support the development of resource-appropriate early detection policies and health systems for the delivery of effective early services. The Cancer Screening in 5 Continents (CanScreen5) project of the Group aims to collect information on characteristics and performance of cancer screening programmes around the world and disseminate such information for informed decision making in cancer screening programmes. For example, the Group significantly contributed also to the evaluation of the safety and efficacy of less than three doses of the HPV vaccine in protecting against cervical cancer.


Visitors and news

EMERGENCY: Coronavirus disease (COVID-19) Pandemic

16/03/2020
Regular updates on the coronavirus disease (COVID-19) outbreak are available at the WHO website.

Virtual conference: Trans NCI-NIH Virtual Conference on International Perspectives on Integrative Medicine for Cancer Prevention and Cancer Patient Management from 27/10/2020 to 30/10/2020

27/10/2020 – 30/10/2020
This virtual conference organized by National Cancer Institute, National Institutes of Health (NCI/NIH) will offer a venue to discuss major public health needs, and to describe current research and development efforts in global cancer integrative oncology Dr Partha Basu, Head of Screening Group, Early Detection & Prevention Section at the International Agency for Research on Cancer will deliver a keynote address about the scopes and challenges of integrative oncology in cancer prevention, therapy and survivorship. View the virtual conference agenda and the session abstracts.

Save the date: Oncology in low-middle income settings: The impact of the COVID-19 pandemic on 16/11/2020

26/10/2020
This webinar organized by the Royal Society of Medicine, UK is part of the London Global Cancer Week 2020 - a series coordinated with over 20 different events providing a comprehensive picture of the impact of the rising incidence of cancer in emerging countries. Join this global movement to address the disparities in cancer care in low and middle income countries, and learn how to address this through collaborative networks. Once again, this webinar will bring together healthcare professionals from around the world to awareness of topical issues globally faced in oncology. View the RSM Oncology Section webinar at London Global Cancer Week 2020 page and the flyer.

CanScreen5 Train the Trainers - Africa Region Live session 2

23/10/2020
Continuation of the CanScreen5 Train the Trainers African course, with participants from 17 African countries. This course has been designed using a blended learning approach, i.e. an approach that uses a mix of e-learning and in-person activities. Today, Dr Suleeporn Sangrajrang deputy director, health system development, National Cancer Institute, Thailand, addressed a key not lecture about cancer screening experience from Thailand. Learn more about the CanScreen5 platform.

Webinar : Battling the breast cancer epidemic in India, on Friday 23 October 2020 at 5.30 pm IST

23/10/2020
Dr Partha Basu, Head of Screening Group, Early Detection & Prevention Section at the International Agency for Research on Cancer invites you to join this webinar organized by the Malabar Cancer Care Society, India, within the framework of breast cancer awareness month 2020. He will be delighted to discuss how to prevent breast cancer in India. Join the webinar (on Friday 23 October 2020 at 5.30 pm IST).

All visitors and news


Scientific papers

Zhao X.L., Liu Z.H., Zhao S., Hu S.Y., Muwonge R., Duan X.Z., Du L.J., Su C.F., Xiang X.E., Zhang X., Pan Q.J., Qiao Y.L., Sankaranarayanan R., Zhao F.H., Basu P. Efficacy of Point-of-care Thermal Ablation Among High-risk Human Papillomavirus Positive Women in China. Int J Cancer. 2020 Sep 7.
PMID: 32895912
Baena A., De Vuyst H., Mesher D., Kasubi M., Yuma S., Mwaiselage J., Zouiouich S., Mlay P., Kahesa C., Landoulsi S., Hernandez M.L., Lucas E., Herrero R., Almonte M., Broutet N. Reproducibility of a rapid human papillomavirus test at different levels of the healthcare system in Tanzania: the AISHA study. Cancer Epidemiol Biomarkers Prev. August 20 2020.
PMID: 32856600
Basu P. Healthcare Systems Need to be Organized to Fight two Pandemics Simultaneously. Asian Pacific Journal of Cancer Care, 5(S1), 1-3.
PMID:

All scientific papers

IARC, 150 Cours Albert Thomas, 69372 Lyon CEDEX 08, France - Tel: +33 (0)4 72 73 84 85 - Fax: +33 (0)4 72 73 85 75
© IARC 2020 - Terms of use  -  Privacy Policy.